Syndrome Pharmaceuticals Private Limited

Pharmaceutical company manufacturing and trading various healthcare products since 2009.

2009 | Patna, Bihar (India) | Active
Last Updated:

Syndrome Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 16 Year, 3 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 23.80%
  • Profit Growth 27.05%
  • Ebitda 24.25%
  • Net Worth 26.36%
  • Total Assets -9.86%

About Syndrome Pharmaceuticals

Syndrome Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2009 and has a history of 16 years. Its registered office is in Patna, Bihar, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.

Sunil Kumar, Kulbhaskar, and Rajesh Kumar serve as directors at the Company.

Company Details

  • Location

    Patna, Bihar, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230BR2009PTC014515

  • Company No.

    014515

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 May 2009

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Patna

Industry

Pharma
Company report

Syndrome Pharmaceuticals Private Limited

Explore comprehensive data for Syndrome Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Syndrome Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Sunil Kumar Country flag representing In Managing Director18-May-2009Current

Board Members (2)

NameDesignationAppointment DateStatus
Kulbhaskar Country flag representing In Director 20-Oct-2014Current
Rajesh Kumar Country flag representing In Additional Director 07-Mar-2016Current

Financial Performance of Syndrome Pharmaceuticals.

Syndrome Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.8% increase. The company also saw a substantial improvement in profitability, with a 27.05% increase in profit. The company's net worth Soared by an impressive increase of 26.36%.

Syndrome Pharmaceuticals revenue growth over time
Syndrome Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
23.80%
Revenue from Operations
23.72%
Total Assets
-9.86%
Profit or Loss
27.05%
Net Worth
26.36%
EBITDA
24.25%

What is the Ownership and Shareholding Structure of Syndrome Pharmaceuticals?

In 2021, Syndrome Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Syndrome Pharmaceuticals?

Unlock and access historical data on people associated with Syndrome Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Syndrome Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Syndrome Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syndrome Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Syndrome Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Syndrome Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Syndrome Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.

  • Director Appointment

    Rajesh Kumar was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2016 & has been associated with this company since 9 years 2 months .

  • Director Appointment

    Kulbhaskar was appointed as a Director was appointed as a Director on 20 Oct 2014 & has been associated with this company since 10 years 7 months .

  • Director Appointment

    Sunil Kumar was appointed as a Managing Director was appointed as a Managing Director on 18 May 2009 & has been associated with this company since 16 years 3 days .

  • Company Incorporation

    Syndrome Pharmaceuticals Private Limited was registered on 18 May 2009 with Roc Patna & aged 16 years 3 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Syndrome Pharmaceuticals Private Limited?

    Syndrome Pharmaceuticals Private Limited was incorporated on 18 May 2009.

  • What is authorized share capital and paid-up capital of Syndrome Pharmaceuticals Private Limited?

    The authorized share capital of Syndrome Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.30 M.

  • Who are the current board members & directors of Syndrome Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Syndrome Pharmaceuticals Private Limited.

    • Sunil Kumar
    • Kulbhaskar
    • Rajesh Kumar

  • What is the registered address of Syndrome Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Syndrome Pharmaceuticals Private Limited is C/O - Lalpati Devi New Bigrahpur Near Bus Stand, Mithapur India, Phulwari, Bihar, 800001.

  • What is the corporate identification number (CIN) and company number of Syndrome Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Syndrome Pharmaceuticals Private Limited is U24230BR2009PTC014515 and the company number is 014515 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Syndrome Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Syndrome Pharmaceuticals Private Limited has risen by 23.80%.

  • What change has been observed in the net worth of Syndrome Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Syndrome Pharmaceuticals Private Limited has experienced an upsurge of 26.36%.

  • When was the last Balance Sheet of Syndrome Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Syndrome Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development